Bioquest Corp

BQSTdata completeness 63%5 fiscal years on file

Data notes: no data for concept 'capex'; no data for concept 'totalDebt'; no data for concept 'pretaxIncome'

The thesis, from the filings

Bioquest Corp earns about -74% on equity, and has bought back 81% of its shares over 5 years. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.

i. The business — what you’d actually own
FigureFY 2013FY 2014FY 2020FY 2021FY 2022
Revenue$01$01
Net income−$8,2772−$487,9922−$359,0293−$2.32M4−$821,0224
Operating cash flow−$7,6295−$472,0765−$124,8346−$193,2067−$116,7207
Capital expenditure
Free cash flow (derived)
Total debt
Cash & equivalents$7,9788$543,8538$1669$26010$33,54010
Diluted shares54.1M54.1M8.0M8.3M10.1M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal
If you owned
shares
Net assets behind them
−$0.43
your share of equity
Profit it earned you last year
−$0.81
Free cash flow it threw off
Debt you’d be carrying

10 shares is a claim on −$0.43 of net worth that earned you −$0.81 last year.

iii. Is this a good business?
Moat signal · return on equity
-74% avg · 5y
FY13 -92%FY14 -56%FY20 FY21 FY22

It earned an average -74% on equity over 5 years. Compare that to what it costs to fund the business.

seeing a moat in the numbers →
Management signal · capital allocation
−81% shares · 5y

Share count is down 81% over 5 years — management has been buying back stock, quietly handing owners a bigger slice.

reading capital allocation →

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0
DCF · Growth Exit 10Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
DCF · Growth Exit 5Y
not applicable
only 0 years of FCF (need ≥3) — model not applicable
Earnings Power Value
not applicable
normalized (5y-median) earnings non-positive — EPV undefined
Graham Number
not applicable
diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts
  1. 10-K · period ending 2013-04-30 · accession 0001019687-14-003533 (Revenues)
  2. 10-K · period ending 2013-04-30 · accession 0001019687-14-003533 (NetIncomeLoss)
  3. 10-K · period ending 2020-04-30 · accession 0001493152-21-019755 (NetIncomeLoss)
  4. 10-K · period ending 2021-04-30 · accession 0001493152-22-022442 (NetIncomeLoss)
  5. 10-K · period ending 2013-04-30 · accession 0001019687-14-003533 (NetCashProvidedByUsedInOperatingActivitiesContinuingOperations)
  6. 10-K · period ending 2020-04-30 · accession 0001493152-21-019755 (NetCashProvidedByUsedInOperatingActivities)
  7. 10-K · period ending 2021-04-30 · accession 0001493152-22-022442 (NetCashProvidedByUsedInOperatingActivities)
  8. 10-K · period ending 2013-04-30 · accession 0001019687-14-003533 (CashAndCashEquivalentsAtCarryingValue)
  9. 10-K · period ending 2020-04-30 · accession 0001493152-21-019755 (CashAndCashEquivalentsAtCarryingValue)
  10. 10-K · period ending 2021-04-30 · accession 0001493152-22-022442 (CashAndCashEquivalentsAtCarryingValue)